Viewing Study NCT05268666


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2026-01-05 @ 3:25 AM
Study NCT ID: NCT05268666
Status: UNKNOWN
Last Update Posted: 2023-06-15
First Post: 2022-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
Sponsor: Jubilant Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module